---
title: "在ADA会议上展示的创新药物数据预示着全面健康改善"
description: "在ADA会议上展示的创新药物数据预示着全面健康改善"

---


:::info

“智闻AI“ 是由人工智能编撰的刊物集合，确保您只获得最有价值的信息，旨在助您消除信息差，突破信息茧房的局限。  [了解更多 >>](/)

:::

# 在ADA会议上展示的创新药物数据预示着全面健康改善

import Tabs from '@theme/Tabs';
import TabItem from '@theme/TabItem';

<Tabs
	defaultValue="summary"
	values={[
	{label: 'summary', value: 'summary'},
	{label: 'score', value: 'score'},
]}>
<TabItem value="summary">


礼来公司及其他制药商在美国糖尿病协会年会上公布了关于减肥和糖尿病治疗的令人鼓舞的数据。这些公司正在探索超越传统GLP-1药物的新方法，不仅关注体重减轻，还关注治疗其他健康状况和保持肌肉质量。

礼来公司的Zepbound，一种减肥注射剂，在近半数患者中显示出解决阻塞性睡眠呼吸暂停的潜力。诺和诺德公司的司美格鲁肽，用于Wegovy和Ozempic，在糖尿病合并慢性肾病患者中显著降低了肾病进展和死亡风险。Zealand Pharma的佩特林肽针对胰淀素激素，在早期试验中导致了显著的体重减轻。Altimmune的pemvidutide在肥胖试验中促进脂肪减少的同时保持了肌肉质量。

这些进展突显了制药研究的一个转变，从单纯的体重减轻转向全面的健康改善。该行业向全面患者护理的转变可能会重新定义代谢疾病治疗的标准。
</TabItem>
<TabItem value="score">
	| Scores     | Value   | Explanation |
	| -------- | ------- | ------- |
	| Objectivity  | 5    | Content is fairly objective, with balanced reporting on various drug developments.    |
	| Social Impact | 4     | Content has sparked strong social discussion on new treatments, influencing public opinion.    |
	| Credibility    | 5    | Content is completely credible, with solid evidence from authoritative sources.    |
	| Potential    | 5    | Content has very high potential to trigger significant changes in metabolic disease treatment.    |
	| Practicality    | 4    | Content is highly practical, directly applicable to real health problems.    |
	| Entertainment Value    | 2    | Content is slightly monotonous but includes informative elements.    |
</TabItem>
</Tabs>

[Full article>>](https://www.cnbc.com/2024/06/26/healthy-returns-eli-lilly-drugmakers-show-off-weight-loss-drug-data.html)
